Literature DB >> 11888765

Dilatation of the autograft root after the Ross operation.

Natascha Simon-Kupilik1, Jan Bialy, Reinhard Moidl, Marie-Theres Kasimir, Martina Mittlböck, Gernot Seebacher, Ernst Wolner, Paul Simon.   

Abstract

OBJECTIVE: Structural differences of the pulmonary root may predispose it to progressive dilatation in the systemic circulation after the Ross operation. We identified the incidence and risk factors of pulmonary autograft root dilatation.
METHODS: One hundred and seven adult patients (mean age of 36+/-11 years) were followed after the Ross operation since 1991 including an echocardiogram within 3 months of surgery and yearly clinical assessment and echocardiography. The autograft was measured at the maximum diameter of the sinus (SV) and aortic insufficiency (AI) assessed. A SV of >37 mm was considered as root dilatation and the incidence over time was calculated using the Kaplan-Meier method. Clinically relevant dilatation was defined as a root diameter of >42 mm. In addition, we determined the percentage change of the sinus diameter between the early and latest echocardiogram. Furthermore we tested the influence of patient variables and risk factors on dilatation.
RESULTS: By 1 year, dilatation was found in 21 patients (20%). The SV was >42 mm in eight patients (7%). By 7 years, only 45% of patients were free of dilatation. Eleven patients (10%) had a SV of >42 mm. Increase in SV was time related and linear. However, 90% of patients showed <25% dilatation during follow-up. Time from operation, early SV diameter, male gender and surgical technique were identified as significant risk factors of dilatation. However, dilatation has not lead to reoperation due to aneurysm formation or development of significant AI.
CONCLUSIONS: We conclude that time dependent autograft root dilation occurs but does not cause an increase in AI and need for reoperation up to 7 years. These findings warrant the pursuit of the concept of the Ross operation in young patients who regain excellent functional status and life style without anticoagulation.

Entities:  

Mesh:

Year:  2002        PMID: 11888765     DOI: 10.1016/s1010-7940(02)00016-7

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

1.  A single center's experience with the Ross procedure in pediatrics.

Authors:  Edward Kirkpatrick; Roger Hurwitz; John Brown
Journal:  Pediatr Cardiol       Date:  2008-04-10       Impact factor: 1.655

2.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan's syndrome.

Authors:  Candice K Silversides; Marla Kiess; Luc Beauchesne; Timothy Bradley; Michael Connelly; Koichiro Niwa; Barbara Mulder; Gary Webb; Jack Colman; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

3.  The Ross procedure in children: a systematic review.

Authors:  Morgan K Moroi; Emile A Bacha; David M Kalfa
Journal:  Ann Cardiothorac Surg       Date:  2021-07

4.  Midterm results of the Ross procedure in a pediatric population: bicuspid aortic valve is not a contraindication.

Authors:  S El Behery; J Rubay; T Sluysmans; B Absil; C Ovaert
Journal:  Pediatr Cardiol       Date:  2009-01-03       Impact factor: 1.655

5.  The Ross procedure utilizing the pulmonary autograft inclusion technique in adults.

Authors:  Vaughn A Starnes; Michael E Bowdish; Robbin G Cohen; Craig J Baker; Ramsey S Elsayed
Journal:  JTCVS Tech       Date:  2021-05-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.